GUILDFORD, UNITED KINGDOM--(Marketwired - Oct 9, 2017) -Angle PLC (OTCQX: ANPCY) (AIM: AGL) AIM: AGL; OTCQX: ANPCY For immediate release 9 October 2017 ANGLE plc ("the Company") ANGLE'S PARSORTIX?,,? SYSTEM SHOWCASED IN MULTIPLE PRESENTATIONS AT LEADING EUROPEAN CIRCULATING TUMOU...Read More
GUILDFORD, SURREY--(Marketwired - Oct 9, 2017) - ANGLE plc (AIM: AGL) (OTCQX: ANPCY) AIM: AGL; OTCQX: ANPCY For immediate release 9 October 2017 ANGLE plc ("the Company") PARSORTIX?,,? SYSTEM CENTRAL TO POTENTIAL NEW ANALYTICAL PROTOCOL FOR IDENTIFYING DRUGS THAT MAY A...Read More
GUILDFORD, SURREY--(Marketwired - Oct 9, 2017) - ANGLE plc (AIM: AGL) (OTCQX: ANPCY), AIM: AGL; OTCQX: ANPCY For immediate release 9 October 2017 ANGLE plc ("the Company") CIRCULATING TUMOUR CELLS, HARVESTED FROM BLOOD, GROWN IN THE LABORATORY FOR THE FIRST TIME Heinr...Read More
GUILDFORD, SURREY--(Marketwired - Oct 5, 2017) -Angle PLC (OTCQX: ANPCY) (AIM: AGL) (AIM: AGL; OTCQX: ANPCY) THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR IN...Read More
GUILDFORD, SURREY--(Marketwired - Oct 5, 2017) - Angle PLC (AIM: AGL) (OTCQX: ANPCY) (AIM:AGL OTCQX:ANPCY) THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FRO...Read More
GUILDFORD, SURREY--(Marketwired - Sep 13, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) (AIM:AGL OTCQX:ANPCY) For immediate release 13 September 2017 ANGLE plc ("the Company") EXCLUSIVE WORLDWIDE OPTION OVER MEGAKARYOCYTE INTELLECTUAL PROPERTY ANGLE signs option over patent applications...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Sep 13, 2017) -(AIM: AGL) (OTCQX: ANPCY) TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Ident...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Sep 11, 2017) - Angle PLC (AIM: AGL) (OTCQX: ANPCY) AIM:AGL; OTCQX:ANPCY ANGLE plc ("the Company") ANGLE ANNOUNCES CO-MARKETING PARTNERSHIP WITH QIAGEN Combines ANGLE's CTC harvesting technology with QIAGEN's downstream analysis and b...Read More
GUILDFORD, SURREY--(Marketwired - Sep 5, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY), (AIM: AGL OTCQX: ANPCY) 5 September 2017 ANGLE plc ("the Company") Change of Adviser ANGLE plc (AIM: AGL OTCQX: ANPCY), a world-leading liquid biopsy company, is pleased to announce the...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Sep 4, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) (AIM: AGL; OTCQX: ANPCY) For immediate release 4 September 2017 ANGLE plc ("the Company") NEW RESEARCH WITH PARSORTIX DEMONSTRATES ABILITY TO IDENTIFY KEY PROTEINS INVOLVED IN BREAST CANCER CELL...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Jul 27, 2017) -ANGLE PLC (AIM: AGL) (OTCQX: ANPCY) For Immediate Release 27 July 2017 OTCQX: ANPCY ANGLE plc ("ANGLE" or "the Company") Preliminary Results for the year ended 30 April 2017 FIRST LARGE SCALE PATIENT STUDIES WITH PARSORTIX COM...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Jul 20, 2017) -ANGLE plc (AIM: AGL) (OTCQX: ANPCY) For immediate release 20 July 2017 ANGLE plc ("the Company") PRECLINICAL STUDY USING PARSORTIX PRESENTED AT TUMOR MODELS BOSTON SUMMIT Parsortix system demonstrates capabilities for use in cancer...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Jul 6, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) For Immediate Release 6 July 2017 AIM:AGL ANGLE plc ("ANGLE" or "the Company") Notification of Preliminary Results and Webcast ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy com...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Jul 4, 2017) -ANGLE plc (AIM: AGL) (OTCQX: ANPCY) (AIM: AGL; OTCQX: ANPCY) For immediate release 4 July 2017 ANGLE plc ("the Company") ANGLE REPORTS SUCCESSFUL HEADLINE DATA IN US AND EUROPEAN OVARIAN CANCER STUDIES IN 400 PATIENTS Parsortix bl...Read More
VANCOUVER, June 8, 2017 /CNW/ - The following issues have been halted by IIROC: Company: Austral Gold Ltd. TSX-Venture Symbol: AGLD Reason: Pending Clarification of News Halt Time (ET): 09:22 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a...Read More
VANCOUVER, June 9, 2017 /CNW/ - Trading resumes in: Company: Austral Gold Ltd. TSX-Venture Symbol: AGLD Resumption (ET): 9:30 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a f...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Apr 3, 2017) -Angle PLC (OTCQX: ANPCY) (AIM: AGL) AIM:AGL, OTCQX:ANPCY For immediate release 3 April 2017 ANGLE plc ("the Company") PARSORTIX ENABLES GENE EXPRESSION ANALYSIS IN HEAD AND NECK CANCER Customer presents clinically r...Read More
GUILDFORD, SURREY--(Marketwired - Apr 4, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) AIM: AGL; OTCQX: ANPCY For immediate release 4 April 2017 ANGLE plc ("the Company") Holding(s) in Company The Company has been informed by Lombard Odier Investment Managers group ("Lombard") that, f...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - May 3, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) AIM:AGL OTCQX:ANPCY For immediate release 3 May 2017 ANGLE plc ("the Company") BUSINESS UPDATE HIGHLIGHTS PROGRESS WITH PARSORTIX LIQUID BIOPSY Ovarian cancer clinical studies progressing well wi...Read More
GUILDFORD, UNITED KINGDOM--(Marketwired - Jun 5, 2017) -Angle PLC (AIM: AGL) (OTCQX: ANPCY) AIM:AGL OTCQX:ANPCY For immediate release 5 June 2017 ANGLE plc ("the Company") SUCCESS WITH PARSORTIX IN COLORECTAL CANCER Clinically relevant results presented at ASCO 2017 cancer conference...Read More